Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

Feb

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Feb

Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Menu

Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

To read the full story....

Breaking News

Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

What's Popular?

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

Infectious Disease Test Firm Talis Biomedical Files for IPO

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay

Sponsorships